Key result
Implantable cardioverter defibrillators are cost-effective in reducing sudden cardiac death and all-cause mortality, though barriers remain in translating guidelines into clinical practice.
Why the study?
Does the implantable cardioverter defibrillator reduce sudden cardiac death and all-cause mortality?
Does the implantable cardioverter defibrillator reduce sudden cardiac death and all-cause mortality?
While ICDs are cost-effective in reducing sudden cardiac death and all-cause mortality, significant barriers prevent full implementation of existing guidelines in clinical practice.
Answers are grounded in this paper and cite their sources.
Barriers to guideline implementation persist; leaves open optimal strategies to improve real-world ICD uptake.
IMPORTANCE: Approximately 350,000 Americans still die of sudden cardiac death each year. This exceeds the number of patients who die annually from stroke, lung cancer, breast cancer and AIDS combined. OBJECTIVE: This review aims to trace the history of implantable cardioverter defibrillators (ICD) with reference to landmark trials and their influence on the formulation of Medicare guidelines for ICD implantation criteria. This paper will also discuss the cost-effectiveness of ICDs and the quality of life after implantation. The reasons for the disparity between guidelines for implantation and actual clinical practice will be elucidated, with suggestions for improving overall clinical performance. RESULTS AND CONCLUSION: The ICD has been shown to be cost-effective in reducing sudden cardiac death and all-cause mortality. However, the existing recommendations for ICD implantation have yet to translate completely into clinical practice. Barriers to implementation of existing guidelines include knowledge gaps in the referring physician practices, lack of validated screening tools to assess patient candidacy for the device and patient understanding of the need for the device. Future strategies to increase compliance with the existing guidelines and improve clinical performance are areas of potential research focus.
No takes yet. Share an insight, caveat, or question.
Rajabali et al. (2013) conducted a review in Sudden cardiac death. Implantable cardioverter defibrillator (ICD) was evaluated. Implantable cardioverter defibrillators are cost-effective in reducing sudden cardiac death and all-cause mortality, though barriers remain in translating guidelines into clinical practice.
Synapse has enriched 10 related papers. Consider them for comparative context: